Need convincing21 Aug 2021 09:51
I am heavily invested in SNG (as well as Novacyt) but am becoming increasing concerend about my investment in view of all the competitor drugs coming on the market the latest being Ronapreve which prevents infection and reduces the need for hospital treatment and has now been approved for use in the UK - all great news for mankind! However, rightly or wrongly, I am beginning to think that if SNG does not become available by the end of this year, it will be overtaken by equally good if not better products. A buy out by a big pharma, therefore, may be necessary to give it the huge boost it sorely needs. I appreciate the drug also has other benefits re respitory infections. I bow to the vastly superior knowledge of many on this bb but unless I hear a comnpelling enough argument for SNG, I think I will be forced to substantially cut back on my SNG holding and plough the proceeds into NCYT which has a far wider range of products and is now on the rise. SNG comes across as too little too late sadly. I am not a deramper.